1 reports of this reaction
7.7% of all CHILDRENS ALLERGY RELIEF reports
#11 most reported adverse reaction
PRODUCT LABEL ISSUE is the #11 most commonly reported adverse reaction for CHILDRENS ALLERGY RELIEF, manufactured by Allegiant Health. There are 1 FDA adverse event reports linking CHILDRENS ALLERGY RELIEF to PRODUCT LABEL ISSUE. This represents approximately 7.7% of all 13 adverse event reports for this drug.
Patients taking CHILDRENS ALLERGY RELIEF who experience product label issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT LABEL ISSUE is moderately reported among CHILDRENS ALLERGY RELIEF users, representing a notable but not dominant share of adverse events.
In addition to product label issue, the following adverse reactions have been reported for CHILDRENS ALLERGY RELIEF:
The following drugs have also been linked to product label issue in FDA adverse event reports:
PRODUCT LABEL ISSUE has been reported as an adverse event in 1 FDA reports for CHILDRENS ALLERGY RELIEF. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT LABEL ISSUE accounts for approximately 7.7% of all adverse event reports for CHILDRENS ALLERGY RELIEF, making it a notable side effect.
If you experience product label issue while taking CHILDRENS ALLERGY RELIEF, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.